Strange: Bullish TXG Analysts Actually See -10.7% Downside
August 20, 2020 at 08:30 AM EDT
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with 10x Genomics Inc (TXG). The average 12-month price target for TXG — averaging the work of 7 analysts — reveals an average price target of $97.14/share..